Amicus Therapeutics, Inc. Banner Image

Amicus Therapeutics, Inc.

  • Ticker FOLD
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Amicus Therapeutics, Inc. Logo Image
  • 501-1000 Employees
  • Based in Philadelphia, Pennsylvania
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolicMore diseases.
4.8 / 5.0 (146)

Amicus Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 146 reviews.

Amicus Therapeutics, Inc.

Most Recent Annual Report

Amicus Therapeutics, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Amicus Therapeutics, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Amicus Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!